Revenue

With a $70M Charleston facility, Red Metals plans to disrupt copper refining. But can its novel process close the supply gap and prove commercially viable?

As retail plunges into the AI era, the upcoming CommerceNext Growth Show tackles the defining challenge: how to innovate without sacrificing brand soul.

Visionary Copper and Gold Mines accelerates its Pt. Leamington project, fueled by a major discovery and an ambitious regional strategy in a historic district.

A new alliance between Made Scientific and Pluristyx promises to slash the time and cost of developing advanced iPSC therapies. But can it deliver on its promise?

A new $43,000 federal investment aims to connect seniors and youth through reading, tackling isolation and strengthening French language roots in Ontario.

Facing dire financial warnings, Cosmos Health plans to sell its own facilities to fund a comeback. Is it a stroke of genius or a desperate final gambit?

A blockbuster drug for chronic illness gets a generic rival, promising huge savings. But is it just about price? A deep dive into the strategy behind the new pill.

A new executive hire at a cultural heritage firm signals a major shift. Can the architects of growth and the guardians of the past build the future together?

Ellucian's recent AI Excellence Award is more than a trophy. It signals a market shift to practical AI, but as the tech matures, are universities ready?

As J.B. Hunt executives prepare to address a key investor conference, all eyes are on their strategy for intermodal dominance and digital freight innovation.

Australian biotech Gelteq is opening a China R&D hub to chase explosive growth, but its bold move into a $60B market comes with significant geopolitical risks.

A new integration between Amplify's AI-native platform and Wealthbox CRM tackles operational drag, signaling a strategic shift toward a more connected future for RIAs.

A pharma revolution is brewing for Generalized Anxiety Disorder. As prevalence soars, novel therapies targeting new neural pathways promise to upend the market.

A 2027 CMS mandate and AI pioneers like Humata Health are racing to fix prior authorization. But can technology truly untangle healthcare's notorious red tape?

As America rebuilds its industrial base, one firm is tearing down silos, offering a single-source solution of capital and real estate to power the economy.

As NEXGEL prepares for a key investor conference, it faces a crucial test: convincing the market its advanced hydrogel tech can overcome recent financial hurdles.

With Aaron Hambleton’s appointment, SecurityHQ signals a strategic shift, betting on deep operational expertise to transform noisy security data into decisive action.

While media giants crumble under VC pressure, a bootstrapped newsletter hits a $101M valuation. Is 1440's quiet, profitable model the answer?

With historic funds flowing and AI's demands soaring, the Broadband Nation Expo is a critical juncture. Can industry leaders overcome the hurdles to connect America?

Eli Lilly's partnership with cash-pay platform Sesame is more than a deal; it's a blueprint for a decentralized, direct-to-consumer healthcare market.